Withaferin A suppresses the expression of vascular endothelial growth factor in Ehrlich ascites tumor cells via Sp1 transcription factor

Current Trends in Biotechnology and Pharmacy

Volumn 3, Issue 2, 2009, Pages 138-148

  Prasanna, Kumar S ^a   Shilpa, P ^a   Salimath, Bharathi P ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Angiogenesis; Ehrlich ascites tumor; Sp1; VEGF; Withaferin A

Indexed keywords

TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; WITHAFERIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL ASSAY; CELL COUNT; CHICK CHORIOALLANTOIC MEMBRANE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; EHRLICH ASCITES TUMOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEUM CANCER; PROMOTER REGION; PROTEIN BINDING; REVIEW;

ANIMALIA; MUS; SOLANACEAE; WITHANIA SOMNIFERA;

EID: 66549124710     PISSN: 09738916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Srinivasan, S., Ranga, R.S., Burikihanov, R., Han, S.S. and Chendil, D. (2007). Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells. Cancer Research, 67: 246-53.
2. Malik, E, Kumar, A., Bhushan, S., Khan, S., Bhatia, A., Suri, K.A., Qazi, G.N. and Singh, J. (2007). Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis, 12: 2115-2133.
3. Sen, N., Banerjee, B., Das, B.B., Ganguly, A., Sen, T., Pramanik, S., Mukhopadhyay, S. and Majumder, H.K. (2007). Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex. Cell Death and Differentiation, 14: 358-367.
4. Mohan, R., Hammers, H.J., Mohan, P.B., Zhan, X.H., Herbstritt, C.J., Ruiz, A., Zhang, L., Hanson, A.D., Conner, B.P., Rougas, J. and Pribluda, V.S. (2004). Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis, 7: 115-122.
5. Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336.
6. Bhattacharya, S.K;, Satyan, K.S. and Ghosal, S. (1997). Antioxidant activity of glycowithanolides from W somnifera in rat brain frontal cortex and striatum. Indian Journal of Experimental Biology, 35: 236-239.
7. Bhattacharya, A., Ghosal, S. and Bhattacharya, S.K. (2001). Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. Journal of Ethnopharmacology, 74: 1-6.
8. Mishra, L.C., Singh, B.B. and Dagenais, S. (2000). Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Alternative Medicine Review, 5: 334-346.
9. Upton, R. (2000). American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz, California.
10. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16: 4604-4613.
11. Feldser, D., Agani, F., Iyer, N.V., Pak, B., Ferreira, G. and Semenza, G.L. (1999). Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Research, 59: 3915-3918.
12. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowiez, D., Fiddes, J.C. and Abraham, J.A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. Journal of Biological Chemistry, 266: 11947-11954.
13. Suske, G. (1999). The Sp-family of transcription factors. Gene, 238: 291-300.
14. Kadonaga, J.T., Jones, K.A., and Tjian, R. (1986). Promoter-specific activation of RNA polymerase H transcription by Sp1. Trends in Biochemical Sciences, 11: 20-23.
15. Cook, T., Gebelein, B. and Urrutia, R. (1999). Biochemical and functional predictions for a growing family of zinc finger transcription factors. Annals of the New York Academy of Sciences, 880: 94-102.
16. Wells, L., Vosseller, K. and Hart, G.W. (2001). Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc. Science, 291: 2376-2823.
17. Shi, Q., Le, X., Abbruzzese, J.L., Peng, Z., Qian, C.N., Tang, H., Xiong, Q., Wang, B., Li, X.C., Xie, K. (2001). Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res, 61: 4143-54.
18. Yao, J.C., Wang, L., Wei, D., Gong, W., Hassan, M., Wu, T. T., Mansfield, P., Ajani, J., Xie, K.(2004) Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer. Clinical Cancer Research, 10: 4109-4117.
19. Gururaj, A.E., Belakavadi M., Venkatesh D.A., Marme D. and Salimath, B.P., (2002). Molecular mechanisms of anti-angiogenic effect of curcumin. Biochemical and Biophysical Research Communications, 297: 934-942.
20. Ilan, N., Mahooti, S. and Madri, J. (1998). Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. Journal of Cell Science, 111: 3621-3631.
21. Gururaj, A.E., Belakavadi, M. and Salimath, B.P. (2003). Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation. Molecular and Cellular Biochemistry, 243: 107-112.
22. Thippeswamy, G., Sheela, M.L. and Salimath. B.P. (2008). Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-êB and its DNA binding activity. European Journal of Pharmacology, 588: 141-50.
23. Belakavadi, M. and Salimath, B.P. (2005). Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-êB and caspase activated DNase. Molecular and Cellular Biochemistry, 273: 57-67.
24. Belakavadi, M., Prabhakar, B.T. and Salimath, B.P. (2005). Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and down regulation of VEGF, Biochemical and Biophysical Research Communications, 335: 993-1001.
25. Salimath, B.P., Marme, D. and Finkenzeller, G. (2000). Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene, 19: 3470-3476.
26. Jayaraman, T., Ondriasova, E., Ondrias, K., Harnick, D.J. and Marks, A.R. (1995). The inositol 1, 4, 5-trisphosphate receptor is essential for T-cell receptor signaling. Proceedings of the National Academy of Sciences, 92: 6007-6011.
27. Prasanna Kumar, S., Thippeswamy, G., Sheela, M.L., Prabhakar, B.T. and Salimath, B.P. (2008). Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1. Archives of Biochemistry and Biophysics, 478: 85-95.
28. Fotsis, T., Pepper, M.S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R. and Schweigerer, L. (1997). Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research, 57: 2916-2921.
29. Budhi-raja, R.D. and Sudhir, S. (1998). Review of biological activity of withanolides. Journal of Scientific and Industrial Research, 46: 488-491.
30. Sethi, P.D., Thiagarajan, A.R. and Subrahamanian, S.S. (1990). Studies on the anti-inflammatory and anti-arthritic activity of withaferin-A. Indian Journal of Pharmacology, 12: 165-172.
31. Uma Devi, P., Sharada, A.C. and Solomon, F.E. (1995). In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Letters, 95: 189-193.
32. Sadick, H., Naim, R., Gossler, U., Hormann, K. and Riedel, F. (2005). Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. International Journal of Molecular Medicine, 15: 15-19.
33. Mesiano, S., Ferrara, N. and Jaffe, R.B. (1998). Role of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibition of Ascites Formation by Immunoneutralization. American Journal of Pathology, 153: 1249-1256.
34. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in-vivo. Nature, 362: 841-844.
35. Prabhakar, B.T., Khanum, S.A., Shashikanth, S. and Salimath, B.P. (2006). Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1 á and down regulation of VEGF in vivo. Investigation of New Drugs, 24: 471-478.
36. Oh, J.H., Lee, T.J., Kim, S.H., Choi, Y.H., Lee, S.H., Lee, J.M., Kim, Y.H., Park, J.W. and Kwon, T.K. (2008). Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis, 13: 1494-504.
37. Oh, J.H., Lee, T.J., Park, J.W. and Kwon, T.K. (2008). Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells. European Journal of Pharmacology, 599: 11-7.
38. Divya, S., Amita, A., Rakesh, M. and Sita, N. (2007). Withania somnifera inhibits NF-êB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytotherapy Research, 21: 905-913.
39. Kaileh, M., Vanden, B.W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T. and Haegeman, G. (2007). Withaferin A strongly elicits IêB Kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. Journal of Biological Chemistry, 282: 4253-4264.
40. Wei, D., Wang, L., He, Y., Henry James, Q.X., Abbruzzese, L. and Xie, K. (2004). Celecoxib Inhibits Vascular Endothelial. Growth Factor Expression in and Reduces Angiogenesis and Metastasis of Human Pancreatic Cancer via Suppression of Sp1 Transcription Factor Activity. Cancer Research, 64: 2030-2038.